I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 42 800 VND Market Closed
Market Cap: 6.6T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Revenue Peer Comparison

Comparables:
H
DHT
C
DCL
D
DMC
D
DHG
T
TRA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Revenue
â‚«2.1T
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
10%
H
HaTay Pharmaceutical JSC
VN:DHT
Revenue
â‚«2T
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
9%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Revenue
â‚«1.1T
CAGR 3-Years
19%
CAGR 5-Years
7%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Revenue
â‚«1.8T
CAGR 3-Years
8%
CAGR 5-Years
-8%
CAGR 10-Years
1%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Revenue
â‚«5T
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
3%
T
Traphaco JSC
VN:TRA
Revenue
â‚«2.3T
CAGR 3-Years
-15%
CAGR 5-Years
-5%
CAGR 10-Years
4%

See Also

What is Imexpharm Corp's Revenue?
Revenue
2.1T VND

Based on the financial report for Jun 30, 2024, Imexpharm Corp's Revenue amounts to 2.1T VND.

What is Imexpharm Corp's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Imexpharm Corp have been 14% over the past three years , 11% over the past five years , and 10% over the past ten years .

Back to Top